Please assess the completion status of the following clinical trial:

Trial Title: Tranexamic Acid in Knee Joint Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* All patients at the participating sites on the waiting list for a unilateral total knee joint replacement~Exclusion Criteria:~* Patients with a history or risk of thrombosis~* Active thromboembolic disease such as deep vein thrombosis, pulmonary embolism and cerebral thrombosis~* Subarachnoid haemorrhage~* Hypersensitivity to tranexamic acid or any of its ingredients.~* Refusal of blood products~* Colour blindness~* Complex hematologic disorders requiring manipulation~* Coagulopathy~* Pregnant and Lactating Women~* Anti-coagulant therapy pre-operatively within 5 days of surgery (warfarin, dabigatran, heparin)~* Severe renal failure (eGFR \<29)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Control (Type: PLACEBO_COMPARATOR): Application of 20ml of normal saline (NaCl 0.9%) topically after implantation of prosthesis and left to sit for two minutes, excess carefully suctioned followed by standard closure with no drains; application of 15ml of normal saline intravenously at the same time prior to release of tourniquet.
- Topical (Type: EXPERIMENTAL): Application of 1.5g in 20ml tranexamic acid topically after implantation of prosthesis with excess carefully suctioned followed by standard closure with no drains; application of 15ml of normal saline intravenously at the same time prior to release of tourniquet.
- Systemic (Type: EXPERIMENTAL): Application of 20ml of normal saline topically after implantation of prosthesis with excess carefully suctioned followed by standard closure with no drains; Application of tranexamic acid intravenously (1.5g/15ml) at the same time prior to release of tourniquet

Based on this trial design, predict the completion outcome and termination type (if applicable).